Cleared Traditional

K935437 - ARBO H85V/H87V/H27V DISPOS MONIT ELECTRODES

K935437 is an FDA 510(k) clearance for ARBO H85V/H87V/H27V DISPOS MONIT ELECTRODES, manufactured by Arbo Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DRX cleared through the Traditional 510(k) pathway after a 512-day FDA review.

K935437 · Arbo Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1995
Decision
512d
Days
Class 2
Risk

K935437 is an FDA 510(k) clearance for the ARBO H85V/H87V/H27V DISPOS MONIT ELECTRODES. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by Arbo Medical, Inc. (Stratford, US). The FDA issued a Cleared decision on April 6, 1995 after a review of 512 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Arbo Medical, Inc. devices

FDA 510(k) Submission Details - K935437

510(k) Number K935437 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 10, 1993
Decision Date April 06, 1995
Days to Decision 512 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
387d slower than avg
Panel avg: 125d · This submission: 512d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRX Device Classification - Class 2, Special Controls

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 97
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K935437.
GRAPHIC CONTROLS BIOTAC JR. ECG ELECTRODE
K950489 · Graphic Controls Corp. · Jul 1995
GRAPHIC CONTROLS Q-TRACE ECG ELECTRODE
K950486 · Graphic Controls Corp. · May 1995
GRAPHIC CONTROLS Q-TRACE GOLD ECG ELECTRODE
K950487 · Graphic Controls Corp. · May 1995
EKG VEST
K932903 · Cardiotronics, Inc. · Feb 1995
QUIK COMBO
K943301 · Physio-Control Corp. · Feb 1995
MEDI-TRACE NEONATAL ECG ELECTRODE WITH PREATTACHED LEADWIRE
K945214 · Graphic Controls Corp. · Nov 1994